Ciprofloxacin And Dexamethasone Suspension/ Drops
Product Images NDC 53746-831

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin And Dexamethasone (NDC 53746-831). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure 1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 1)

FDA Label Image

Structure 2 (Ciprofloxacin And Dexamethasone Otic Suspension Us 2)

FDA Label Image

1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 3)

FDA Label Image

1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 4)

FDA Label Image

1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 5)

FDA Label Image

1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 6)

FDA Label Image

1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 7)

FDA Label Image

1 (Ciprofloxacin And Dexamethasone Otic Suspension Us 8)

FDA Label Image

2 (Ciprofloxacin And Dexamethasone Otic Suspension Us 9)

This text contains information related to a medication called Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP for use in the ears only. It includes details about the active and inactive ingredients, dosage instructions, storage conditions, and manufacturer's information. The medication is sterile and should be discarded after therapy is complete. It also mentions shaking the suspension well before use. Additionally, it provides information about the distributor and manufacturing unit.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.